Therapeutic methods involving gastrointestinal implants
AssigneeGI Dynamics, Inc.
InventorScott Schorer
Life of this patent
Estimating the term…
Abstract
The present invention provides combination therapies for treating a metabolic disorder, such as type 2 diabetes, obesity, and related comorbidities (e.g., NASH or NAFLD)) in an individual undergoing treatment with a gastrointestinal implant. The combination therapies described herein include methods for treating an individual with a gastrointestinal implant with a metabolic agent, a bariatric procedure, and/or a microbiota modulator.
Claims16
A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant, the method comprising administering one or more metabolic agents to the individual in an amount and for a duration to treat the metabolic disorder.
2-22. (canceled)
A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant, the method comprising performing one or more bariatric procedures to treat the metabolic disorder.
24-30. (canceled)
A method of treating a metabolic disorder in an individual undergoing treatment with a gastrointestinal implant, the method comprising administering one or more microbiota modulators to an individual in an amount and for a duration to treat the metabolic disorder.
32-52. (canceled)
Dependencies are inferred from the claim text.